Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117855908 | 11785590 | 8 | F | 20151210 | 20160715 | 20151130 | 20160720 | EXP | PHHY2015CA152789 | NOVARTIS | 74.75 | YR | M | Y | 0.00000 | 20160720 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117855908 | 11785590 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, QMO | 21008 | 20 | MG | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117855908 | 11785590 | 1 | Anaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117855908 | 11785590 | HO |
| 117855908 | 11785590 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117855908 | 11785590 | Ascites | |
| 117855908 | 11785590 | Asthenia | |
| 117855908 | 11785590 | Blood pressure decreased | |
| 117855908 | 11785590 | Gait disturbance | |
| 117855908 | 11785590 | Haemorrhage | |
| 117855908 | 11785590 | Phlebitis | |
| 117855908 | 11785590 | Product use issue | |
| 117855908 | 11785590 | Terminal state |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117855908 | 11785590 | 1 | 20120918 | 20160628 | 0 |